Also known as: WHO, World Health Organisation
WHO set the 2026-2027 northern hemisphere flu vaccine strains. Its FVIVA assessment says improved universal vaccines could prevent 18 billion cases and save 6.2 million lives by 2050.
A multi-ancestry GWAS identified 140 loci associated with age-related hearing loss, including 44 novel signals. The study highlights the inner ear's role and links genetic risk to behavioral traits. It provides new insights into the genetic architecture of this prevalent condition.
The WHO approved the first malaria drug for infants weighing under 5kg, and researchers unveiled a single-dose compound, cabamiquine, showing promise in early trials. Investment in the Medicines for Malaria Venture yielded $13 in health benefits per $1 invested, averting 1.6 million deaths.
Real-world studies show nirsevimab reduced RSV infant hospitalizations by up to 72% and maternal vaccination cut hospitalizations by nearly 70%, with benefits extending into the second RSV season.
Clinical trials show a pancreatic cancer drug nearly doubles survival, a head-and-neck therapy shrinks tumors, and new research explains drug resistance. Cancer mortality is falling in the US and UK.
AstraZeneca is expanding in China with a $200m upfront COPD drug license from Sino Biopharmaceutical, a $1.5bn licensing deal for Dizal's Zegfrovy, and a $15bn manufacturing and R&D investment. The deals add revenue-generating assets to its respiratory and oncology portfolios.
A Cochrane review found intermittent fasting did not beat standard diet advice for weight loss. A separate trial found it matched calorie restriction but felt less restrictive. Experts advise a case-by-case approach given limited evidence.
Oncotelic granted Lunai Bioworks worldwide rights to its nose-to-brain delivery system for biodefense and Alzheimer's. Nearly 98% of small-molecule drugs fail to cross the blood-brain barrier.
FDA granted rolling review for Palvella's QTORIN rapamycin NDA. Also covered: global expedited approval pathways, accelerated approval scrutiny, and multi-regional CDx strategies.
The Bundibugyo Ebola outbreak in the DRC has surpassed 3,200 cases and 1,400 deaths, becoming the fastest-spreading Ebola outbreak ever. The first-ever Bundibugyo-specific vaccine trial has begun at Oxford, while healthcare workers at the epicenter have gone on strike over unpaid wages. The WHO has declared the outbreak a global health emergency.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07432126 |
Community Health Workers Led Integrated Management of Hypertension and Diabetes in Nepal |
RECRUITING | NA |
| NCT07236268 |
Prevalence of HIV and Sexually Transmitted Infections in Migrant Communities in Slovakia |
COMPLETED | |
| NCT07145736 |
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases |
RECRUITING | PHASE4 |
| NCT07129837 |
Serum Anti-PCOLCE as Novel Diagnostic Biomarker in Rheumatoid Arthritis With Emphasis on Seronegative Patients. |
NOT_YET_RECRUITING | |
| NCT07116447 |
Impact of Alcohol Health Messages in a Real-world Online Retail Setting |
COMPLETED | NA |
| NCT07071792 |
Prevalence of Helmet Associated Neck Pain Among TCS Riders |
COMPLETED | |
| NCT07012876 |
Effectiveness of a Guided Mental Health Chatbot for Youth Living in Lithuania |
ACTIVE_NOT_RECRUITING | NA |
| NCT07008950 |
Self-efficacy and Knowledge (SEEK) Trial to Improve Sexual Reproductive Health and Well-being for Syrian Refugee Women and Girls in Lebanon |
RECRUITING | NA |
| NCT06989398 |
Implementation of the ASCEND Training for Supervisors in Dutch Small and Medium-sized Enterprises (SMEs) |
RECRUITING | NA |
| NCT06979089 |
Implementation of WHO's Doing What Matters in Times of Stress in Dutch Small and Medium-sized Enterprises (SMEs) |
RECRUITING | NA |
